Nasdaq Denies ENvue Medical's Listing Appeal; Stock Moves to OTC
FEED is trading near its 52-week low of $2.77 (0.0% above the low).
Summary
The Nasdaq Hearings Panel denied ENvue Medical's request for continued listing, forcing the stock to the OTC Markets starting September 16, 2026. This follows the July 10 delisting notice and the September 1 reverse split that failed to restore compliance. The move to OTC will likely reduce liquidity and widen spreads, adding pressure to a stock already trading near its 52-week low. The company is evaluating appeal options, but no timeline is given. With only $1.084M in cash and a going concern warning, the delisting compounds existing financial distress.
At the time of this announcement, FEED was trading at $2.77 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $2.77 to $208.80. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.